Cargando…

Immunotherapy and the Treatment of Non–Small Cell Lung Cancer

Detalles Bibliográficos
Autor principal:	Walker, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679046/ https://www.ncbi.nlm.nih.gov/pubmed/29152394

Ejemplares similares

Immunotherapy for Non-Small Cell Lung Cancer
por: Yoon, Sung Ho
Publicado: (2014)

Biomarkers of immunotherapy in non-small cell lung cancer
por: Wang, Lingling, et al.
Publicado: (2020)

Nanomedicine in Non-Small Cell Lung Cancer: From Conventional Treatments to Immunotherapy
por: García-Fernández, Coral, et al.
Publicado: (2020)

Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non–Small Cell Lung Cancer
por: Waxman, Elizabeth S., et al.
Publicado: (2016)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

First line Immunotherapy for Non-Small Cell Lung Cancer
por: Nasser, Nicola J., et al.
Publicado: (2020)

Neoadjuvant immunotherapy in resectable non-small-cell lung cancer
por: Chen, Lanyi Nora, et al.
Publicado: (2023)

Immunotherapy through the Lens of Non-Small Cell Lung Cancer
por: Stanley, Robyn, et al.
Publicado: (2023)

Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
por: Adderley, H., et al.
Publicado: (2020)

Immunotherapy in Small Cell Lung Cancer
por: Esposito, Giovanna, et al.
Publicado: (2020)

Potential role of immunotherapy in advanced non-small-cell lung cancer
por: de Mello, Ramon Andrade, et al.
Publicado: (2016)

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
por: Barnet, Megan B., et al.
Publicado: (2018)

Review of checkpoint immunotherapy for the management of non-small cell lung cancer
por: Raju, Shine, et al.
Publicado: (2018)

Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
por: Miura, Yosuke, et al.
Publicado: (2018)

Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
por: Sa, Huanlan, et al.
Publicado: (2019)

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
por: Kang, Jin, et al.
Publicado: (2021)

Chemotherapy: A partnership with immunotherapy in non‐small cell lung cancer
por: Mendes, Ana Sofia, et al.
Publicado: (2022)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shang, Shijie, et al.
Publicado: (2021)

The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer
por: Spagnuolo, Alessia, et al.
Publicado: (2023)

Immunotherapy in non-small cell lung cancer: Update and new insights
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2021)

Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
por: Guo, Hanfei, et al.
Publicado: (2021)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Immunotherapy in oncogene addicted non-small cell lung cancer
por: McLean, Luke, et al.
Publicado: (2021)

Immunotherapy in extensive small cell lung cancer
por: Verma, Vaibhav, et al.
Publicado: (2019)

Early palliative care of non-small cell lung cancer in the context of immunotherapy
por: Pieniążek, Małgorzata, et al.
Publicado: (2020)

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Chiu, Li-Chung, et al.
Publicado: (2021)

The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
por: Perdrizet, Kirstin, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
por: Suraya, Ratoe, et al.
Publicado: (2022)

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
por: Russano, Marco, et al.
Publicado: (2023)

Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer
por: Jagieła, Joanna, et al.
Publicado: (2021)

Metastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment paradigm with immunotherapies
por: Scarpace, Sarah L
Publicado: (2015)

Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles
por: Cho, Ju Hwan
Publicado: (2017)

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
por: Lim, Sun Min, et al.
Publicado: (2020)

Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
por: Li, Chu-Ling, et al.
Publicado: (2021)

Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Mojsak, Damian, et al.
Publicado: (2021)

Extracellular Vesicles in Non-Small-Cell Lung Cancer: Functional Role and Involvement in Resistance to Targeted Treatment and Immunotherapy
por: Pasini, Luigi, et al.
Publicado: (2019)

Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
por: Zhang, Anqi, et al.
Publicado: (2022)

Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices
por: Roque, Katia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k1uahmudt7gebk33hea3kssv2j